Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Organogenesis Holdings Inc.ORGO · Entity 6275 | 10% owner | November 18, 2022 | November 22, 2022 |
| Perfumania Holdings, Inc.PERF · Entity 172127 | Director · President and CEO | October 11, 2017 | October 13, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Organogenesis Holdings Inc.
Report date November 18, 2022 · Filed November 22, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 76,382 |
Ending reported balance
After 2022-11-21 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2022-11-18 · Purchase · Acquired 3,000 · Balance 73,382 Row 2 · 2022-11-21 · Purchase · Acquired 3,000 · Balance 76,382 |
Perfumania Holdings, Inc.
Report date October 11, 2017 · Filed October 13, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-10-11 transaction · row 1
1 source rowRow 1 · 2017-10-11 · Disposition to issuer · Disposed 9,127 · Balance 0 F1: In order to facilitate the reorganization of the issuer under Chapter 11 of the Bankruptcy Code, these securities (which had no value) were cancelled for no consideration upon effectiveness of the issuer's Plan of Reorganization. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.26 · Expires 2022-04-02 | Direct | 0 |
Reported balance
After 2017-10-11 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-10-11 · Disposition to issuer · Disposed 150,000 · Balance 0 F1: In order to facilitate the reorganization of the issuer under Chapter 11 of the Bankruptcy Code, these securities (which had no value) were cancelled for no consideration upon effectiveness of the issuer's Plan of Reorganization. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.60 · Expires 2025-01-25 | Direct | 0 |
Reported balance
After 2017-10-11 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2017-10-11 · Disposition to issuer · Disposed 100,000 · Balance 0 F1: In order to facilitate the reorganization of the issuer under Chapter 11 of the Bankruptcy Code, these securities (which had no value) were cancelled for no consideration upon effectiveness of the issuer's Plan of Reorganization. |
Filing footnotes · ownership attribution and instrument terms
F1: In order to facilitate the reorganization of the issuer under Chapter 11 of the Bankruptcy Code, these securities (which had no value) were cancelled for no consideration upon effectiveness of the issuer's Plan of Reorganization.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 21, 2022 Filed Nov 22, 2022 20:29 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A Common Stock | 3,000 | $2.56 | $7,680.00 |
DisclosureSEC source: 0001062993-22-022671 · form4.xml · nonDerivative · entry 2 KATZ MICHAEL W · CIK 0001279930 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,382 Read SEC document |
| November 18, 2022 Filed Nov 22, 2022 20:29 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A Common Stock | 3,000 | $2.57 | $7,710.00 |
DisclosureSEC source: 0001062993-22-022671 · form4.xml · nonDerivative · entry 1 KATZ MICHAEL W · CIK 0001279930 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,382 Read SEC document |
| May 16, 2022 Filed May 18, 2022 17:04 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A Common Stock | 3,000 | $6.10 | $18,300.00 |
DisclosureSEC source: 0001062993-22-012917 · form4.xml · nonDerivative · entry 3 KATZ MICHAEL W · CIK 0001279930 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,382 Read SEC document |
| May 16, 2022 Filed May 18, 2022 17:04 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A Common Stock | 3,000 | $6.02 | $18,057.00 |
DisclosureSEC source: 0001062993-22-012917 · form4.xml · nonDerivative · entry 2 KATZ MICHAEL W · CIK 0001279930 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,382 Read SEC document |
| May 16, 2022 Filed May 18, 2022 17:04 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A Common Stock | 4,000 | $5.99 | $23,940.80 |
DisclosureSEC source: 0001062993-22-012917 · form4.xml · nonDerivative · entry 1 KATZ MICHAEL W · CIK 0001279930 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,382 Read SEC document |
| December 13, 2021 Filed Dec 14, 2021 18:47 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A Common Stock | 500 | $9.65 | $4,825.00 |
DisclosureSEC source: 0001062993-21-012871 · form4.xml · nonDerivative · entry 1 KATZ MICHAEL W · CIK 0001279930 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,382 Read SEC document |
| December 03, 2021 Filed Dec 6, 2021 17:48 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A Common Stock | 800 | $9.35 | $7,480.00 |
DisclosureSEC source: 0001062993-21-012263 · form4.xml · nonDerivative · entry 3 KATZ MICHAEL W · CIK 0001279930 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,882 Read SEC document |
| December 02, 2021 Filed Dec 6, 2021 17:48 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A Common Stock | 800 | $9.55 | $7,640.00 |
DisclosureSEC source: 0001062993-21-012263 · form4.xml · nonDerivative · entry 2 KATZ MICHAEL W · CIK 0001279930 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,082 Read SEC document |
| December 02, 2021 Filed Dec 6, 2021 17:48 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A Common Stock | 1,000 | $9.75 | $9,750.00 |
DisclosureSEC source: 0001062993-21-012263 · form4.xml · nonDerivative · entry 1 KATZ MICHAEL W · CIK 0001279930 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,282 Read SEC document |
| November 29, 2021 Filed Dec 1, 2021 18:17 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A Common Stock | 1,000 | $9.75 | $9,750.00 |
DisclosureSEC source: 0001062993-21-011910 · form4.xml · nonDerivative · entry 1 KATZ MICHAEL W · CIK 0001279930 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,282 Read SEC document |
| November 26, 2021 Filed Nov 30, 2021 20:15 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A Common Stock | 1,000 | $9.75 | $9,750.00 |
DisclosureSEC source: 0001062993-21-011825 · form4.xml · nonDerivative · entry 2 KATZ MICHAEL W · CIK 0001279930 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,282 Read SEC document |
| November 26, 2021 Filed Nov 30, 2021 20:15 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A Common Stock | 1,000 | $9.82 | $9,820.00 |
DisclosureSEC source: 0001062993-21-011825 · form4.xml · nonDerivative · entry 1 KATZ MICHAEL W · CIK 0001279930 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,282 Read SEC document |
| November 17, 2021 Filed Nov 19, 2021 17:03 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A Common Stock | 1,000 | $10.87 | $10,870.00 |
DisclosureSEC source: 0001661181-21-000071 · edgar.xml · nonDerivative · entry 4 KATZ MICHAEL W · CIK 0001279930 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,282 Read SEC document |
| November 15, 2021 Filed Nov 19, 2021 17:03 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A Common Stock | 1,000 | $11.08 | $11,080.00 |
DisclosureSEC source: 0001661181-21-000071 · edgar.xml · nonDerivative · entry 3 KATZ MICHAEL W · CIK 0001279930 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,282 Read SEC document |
| November 12, 2021 Filed Nov 19, 2021 17:03 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A Common Stock | 1,000 | $11.00 | $11,000.00 |
DisclosureSEC source: 0001661181-21-000071 · edgar.xml · nonDerivative · entry 2 KATZ MICHAEL W · CIK 0001279930 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,282 Read SEC document |
| November 12, 2021 Filed Nov 19, 2021 17:03 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A Common Stock | 2,000 | $11.30 | $22,600.00 |
DisclosureSEC source: 0001661181-21-000071 · edgar.xml · nonDerivative · entry 1 KATZ MICHAEL W · CIK 0001279930 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,282 Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 19:38 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A Common Stock | 12,000 | $13.55 | $162,600.00 |
DisclosureSEC source: 0001661181-21-000066 · edgar.xml · nonDerivative · entry 1 KATZ MICHAEL W · CIK 0001279930 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,282 F1 · price: The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $13.34 to $13.68, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4. Read SEC document |
| November 17, 2020 Filed Nov 19, 2020 17:21 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A Common Stock | 20,829 | $3.25 | $67,694.25 |
DisclosureSEC source: 0001661181-20-000043 · edgar.xml · nonDerivative · entry 1 KATZ MICHAEL W · CIK 0001279930 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,432 Read SEC document |
| September 13, 2019 Filed Sep 16, 2019 16:59 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A Common Stock | 3,603 | $6.00 | $21,618.00 |
DisclosureSEC source: 0001661181-19-000021 · edgar.xml · nonDerivative · entry 1 KATZ MICHAEL W · CIK 0001279930 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,603 Read SEC document |
| September 04, 2019 Filed Sep 5, 2019 20:19 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A Common Stock | 10,000 | $4.50 | $44,975.00 |
DisclosureSEC source: 0001661181-19-000008 · edgar.xml · nonDerivative · entry 1 KATZ MICHAEL W · CIK 0001279930 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 F1 · price: The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $4.495 to $4.50, inclusive. The reporting person undertakes to provide to Organogenesis Holdings Inc. ("ORGO"), any security holder of ORGO, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4. Read SEC document |
| May 22, 2019 Filed May 24, 2019 16:29 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $7.08 | $0.00 |
DisclosureSEC source: 0001661181-19-000002 · edgar.xml · derivative · entry 1 KATZ MICHAEL W · CIK 0001279930 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2029-05-22 F1 · derivative.exercise_date: The shares underlying the option shall vest 20% annually beginning on May 22, 2020 and will be fully vested on May 22, 2024. Read SEC document |
| October 11, 2017 Filed Oct 13, 2017 16:32 UTC | Perfumania Holdings, Inc. PERF · Entity 172127 | Disposition to issuerStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $5.60 | $0.00 |
DisclosureSEC source: 0000908662-17-000208 · edgar.xml · derivative · entry 3 KATZ MICHAEL W · CIK 0001279930 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 100,000 shares Expires 2025-01-25 F1 · kind: In order to facilitate the reorganization of the issuer under Chapter 11 of the Bankruptcy Code, these securities (which had no value) were cancelled for no consideration upon effectiveness of the issuer's Plan of Reorganization. Read SEC document |
| October 11, 2017 Filed Oct 13, 2017 16:32 UTC | Perfumania Holdings, Inc. PERF · Entity 172127 | Disposition to issuerStock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $9.26 | $0.00 |
DisclosureSEC source: 0000908662-17-000208 · edgar.xml · derivative · entry 2 KATZ MICHAEL W · CIK 0001279930 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 150,000 shares Expires 2022-04-02 F1 · kind: In order to facilitate the reorganization of the issuer under Chapter 11 of the Bankruptcy Code, these securities (which had no value) were cancelled for no consideration upon effectiveness of the issuer's Plan of Reorganization. Read SEC document |
| October 11, 2017 Filed Oct 13, 2017 16:32 UTC | Perfumania Holdings, Inc. PERF · Entity 172127 | Disposition to issuerCommon Stock | 9,127 | $0.00 | $0.00 |
DisclosureSEC source: 0000908662-17-000208 · edgar.xml · nonDerivative · entry 1 KATZ MICHAEL W · CIK 0001279930 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: In order to facilitate the reorganization of the issuer under Chapter 11 of the Bankruptcy Code, these securities (which had no value) were cancelled for no consideration upon effectiveness of the issuer's Plan of Reorganization. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.